Research Article

Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy

Table 2

First-line chemotherapeutic regimens.

First-line chemotherapy (%)Before pemetrexed approvalAfter pemetrexed approval

Platinum-based chemotherapy with pemetrexed43 (30.9%)043
Cisplatin/doxorubicin with or without tamoxifen32 (23.0%)320
Platinum-based chemotherapy with gemcitabine18 (12.9%)153
Gemcitabine15 (10.8%)150
Gefitinib 10 (7.2%)010
Other regimens (each regimen representing <5%)21 (15.1%)1011